Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 8,029 shares at $1.15 ($9K) on 2024-11-01, disclosed to the SEC on 2024-12-05.
Scheduled purchase ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.15 | 380 | $437 | 4.7% |
| 2 | $1.17 | 245 | $287 | 3.1% |
| 3 | $1.20 | 380 | $456 | 4.9% |
| 4 | $1.20 | 380 | $456 | 4.9% |
| 5 | $1.17 | 380 | $445 | 4.8% |
| 6 | $1.18 | 380 |
| $448 |
| 4.8% |
| 7 | $1.20 | 380 | $456 | 4.9% |
| 8 | $1.20 | 380 | $456 | 4.9% |
| 9 | $1.20 | 380 | $456 | 4.9% |
| 10 | $1.19 | 380 | $452 | 4.8% |
| 11 | $1.17 | 380 | $445 | 4.8% |
| 12 | $1.18 | 380 | $448 | 4.8% |
| 13 | $1.15 | 380 | $437 | 4.7% |
| 14 | $1.13 | 427 | $483 | 5.2% |
| 15 | $1.09 | 427 | $465 | 5.0% |
| 16 | $1.07 | 474 | $507 | 5.4% |
| 17 | $1.09 | 474 | $517 | 5.5% |
| 18 | $1.11 | 474 | $526 | 5.6% |
| 19 | $1.15 | 474 | $545 | 5.8% |
| 20 | $1.32 | 474 | $626 | 6.7% |
| Total | $1.16 avg | 8,029 | $9K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |